NCT00047476已完成2 期
Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of d-MPH in the Treatment of Fatigue and Neurobehavioral Impairment Related to Chemotherapy in Adult Cancer Patients
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 160
- 试验地点
- 42
研究概览
简要总结
To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (42)
Loading locations...
相似试验
已完成
3 期
Methylphenidate in Treating Patients With MelanomaFatigueUnspecified Adult Solid Tumor, Protocol SpecificNCT00003266Eastern Cooperative Oncology Group200
已完成
4 期
Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.Attention-Deficit/Hyperactivity Disorder (ADHD)NCT00776009Novartis Pharmaceuticals165
已完成
3 期
Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD)Attention Deficit Hyperactivity DisorderNCT00482313Psychiatry Karolinska30
已完成
1 期
Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRefractory Multiple MyelomaNCT01049945Mayo Clinic70
已完成
4 期
A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)Attention Deficit Hyperactivity DisorderNCT00564954Novartis Pharmaceuticals86